Sygnature Discovery

News

Just a few months after emerging from stealth, the UK's DaltonTx has launched its AI in drug discovery platform and revealed its first client.

News

Tarsus agrees to buy Alkeus in an $800m deal that will give it rights to a drug for eye disorder Stargardt disease with "blockbuster potential."

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.